These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9767974)

  • 21. [Ecstasy toxicity].
    Reingardiene D
    Medicina (Kaunas); 2006; 42(6):519-23. PubMed ID: 16816548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe dilated cardiomyopathy as a consequence of Ecstasy intake.
    Mizia-Stec K; Gasior Z; Wojnicz R; Haberka M; Mielczarek M; Wierzbicki A; Pstraś K; Hartleb M
    Cardiovasc Pathol; 2008; 17(4):250-3. PubMed ID: 18402796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: multidetector CT and pathology findings.
    Lawler LP; Abraham S; Fishman EK
    J Comput Assist Tomogr; 2001; 25(4):649-52. PubMed ID: 11473199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High incidence of mild hyponatraemia in females using ecstasy at a rave party.
    van Dijken GD; Blom RE; Hené RJ; Boer WH; NIGRAM Consortium
    Nephrol Dial Transplant; 2013 Sep; 28(9):2277-83. PubMed ID: 23476039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.
    O'Suilleabhain P; Giller C
    Mov Disord; 2003 Nov; 18(11):1378-81. PubMed ID: 14639685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective neurocognitive deficits associated with multiple doses of ecstasy/MDMA: a reply to Cole.
    Fox HC; Parrott AC
    J Psychopharmacol; 2003 Jun; 17(2):242-4. PubMed ID: 12870575
    [No Abstract]   [Full Text] [Related]  

  • 27. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.
    Campbell GA; Rosner MH
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1852-60. PubMed ID: 18684895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ecstasy: pharmacology and neurotoxicity.
    Morton J
    Curr Opin Pharmacol; 2005 Feb; 5(1):79-86. PubMed ID: 15661630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological and psychopathological sequelae associated with a lifetime intake of 40,000 ecstasy tablets.
    Kouimtsidis C; Schifano F; Sharp T; Ford L; Robinson J; Magee C
    Psychosomatics; 2006; 47(1):86-7. PubMed ID: 16384814
    [No Abstract]   [Full Text] [Related]  

  • 31. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute giant cell hepatitis in a 17-year old man].
    Muñoz P; Drobinska A; Bianchi L; Züger Ch; Pirovino M
    Praxis (Bern 1994); 2004 Dec; 93(50):2109-12. PubMed ID: 15646679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ecstasy (MDMA) and oral health.
    Brand HS; Dun SN; Nieuw Amerongen AV
    Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumomediastinum following Ecstasy (methylenedioxymetamphetamine, MDMA) ingestion in two people at the same 'rave'.
    Rejali D; Glen P; Odom N
    J Laryngol Otol; 2002 Jan; 116(1):75-6. PubMed ID: 11860664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cerebral hemorrhage and "ecstasy"].
    Schlaeppi M; Prica A; de Torrenté A
    Praxis (Bern 1994); 1999 Mar; 88(13):568-72. PubMed ID: 10235031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fulminant Budd-Chiari syndrome due to ecstasy.
    Taş A; Kara B; Yılmaz C; Suat Yalçın M; Dilek O; Olmez S; Saritas B
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):e12-e13. PubMed ID: 27459877
    [No Abstract]   [Full Text] [Related]  

  • 37. Contraction band necrosis in two ecstasy abusers: a latent lethal lesion associated with ecstasy.
    Hua YS; Liang R; Liang L; Huang GZ
    Am J Forensic Med Pathol; 2009 Sep; 30(3):295-7. PubMed ID: 19696592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatic and hematological complications following ecstasy usage].
    Shibolet O; Kalish Y; Gillis S; Ilan Y
    Harefuah; 2001 Oct; 140(10):911-4, 991. PubMed ID: 11681122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis.
    Brncić N; Kraus I; Visković I; Mijandrusić-Sincić B; Vlahović-Palcevski V
    Med Sci Monit; 2006 Nov; 12(11):CS107-9. PubMed ID: 17072276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.